Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Rheumatology (Oxford) ; 56(6): 1031-1038, 2017 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-28339625

RESUMO

Objectives: Salivary cystatin S is a defence protein mainly produced by submandibular glands and involved in innate oral immunity. This study aimed to verify whether cystatin S was diversely expressed in different disease subsets of primary Sjogren's syndrome (pSS) patients, defined on the basis of salivary flow [unstimulated salivary flow rate (USFR)], minor salivary gland (MSG) focus score and submandibular gland ultrasonography abnormalities. We also evaluated miR-126 and miR-335-5p expression in MSG biopsies to verify whether an aberrant regulation of cystatin S at the glandular level may influence its salivary expression. Methods: Forty pSS patients and 20 sex- and age-matched healthy volunteers were included. Salivary cystatin S levels were assessed by western blot analysis using a stain-free technology. The expression of miR-126, miR-335-5p and cystatin S was assessed by quantitative PCR in 15 MSG biopsies differing for USFR and MSG focus score. Results: We found that salivary cystatin S was significantly decreased in pSS patients vs healthy volunteers ( P = 0.000), especially in those with hyposalivation. A positive correlation was observed between cystatin S and USFR ( r = 0.75, P = 0.01). Salivary cystatin S was also significantly reduced in patients with a submandibular gland ultrasonography score ⩾2. The expression levels of miR-126 and miR-335-5P increased in inverse proportion with USFR. The mRNA of cystatin S did not change significantly, suggesting post-transcriptional regulation. Conclusion: Cystatin S emerged as a promising biomarker for pSS, strongly correlated with glandular dysfunction. An upregulation of miR-126 and miR-335-5P might be implicated in its expression.


Assuntos
Cistatinas Salivares/metabolismo , Síndrome de Sjogren/complicações , Doenças da Glândula Submandibular/etiologia , Biomarcadores/metabolismo , Estudos de Casos e Controles , Feminino , Humanos , MicroRNAs/metabolismo , MicroRNAs/fisiologia , Pessoa de Meia-Idade , Saliva/metabolismo , Síndrome de Sjogren/metabolismo , Glândula Submandibular/metabolismo , Doenças da Glândula Submandibular/metabolismo
2.
Front Cell Dev Biol ; 12: 1385712, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38882056

RESUMO

Mesenchymal stromal/stem cells (MSCs) are a heterogeneous population of multipotent cells that can be obtained from various tissues, such as dental pulp, adipose tissue, bone marrow and placenta. MSCs have gained importance in the field of regenerative medicine because of their promising role in cell therapy and their regulatory abilities in tissue repair and regeneration. However, a better characterization of these cells and their products is necessary to further potentiate their clinical application. In this study, we used unbiased high-resolution mass spectrometry-based proteomic analysis to investigate the impact of distinct priming strategies, such as hypoxia and IFN-γ treatment, on the composition and therapeutic functionality of the secretome produced by MSCs derived from the amniotic membrane of the human placenta (hAMSCs). Our investigation revealed that both types of priming improved the therapeutic efficacy of hAMSCs, and these improvements were related to the secretion of functional factors present in the conditioned medium (CM) and exosomes (EXOs), which play crucial roles in mediating the paracrine effects of MSCs. In particular, hypoxia was able to induce a pro-angiogenic, innate immune response-activating, and tissue-regenerative hAMSC phenotype, as highlighted by the elevated production of regulatory factors such as VEGFA, PDGFRB, ANGPTL4, ENG, GRO-γ, IL8, and GRO-α. IFN-γ priming, instead, led to an immunosuppressive profile in hAMSCs, as indicated by increased levels of TGFB1, ANXA1, THBS1, HOMER2, GRN, TOLLIP and MCP-1. Functional assays validated the increased angiogenic properties of hypoxic hAMSCs and the enhanced immunosuppressive activity of IFN-γ-treated hAMSCs. This study extends beyond the direct priming effects on hAMSCs, demonstrating that hypoxia and IFN-γ can influence the functional characteristics of hAMSC-derived secretomes, which, in turn, orchestrate the production of functional factors by peripheral blood cells. This research provides valuable insights into the optimization of MSC-based therapies by systematically assessing and comparing the priming type-specific functional features of hAMSCs. These findings highlight new strategies for enhancing the therapeutic efficacy of MSCs, particularly in the context of multifactorial diseases, paving the way for the use of hAMSC-derived products in clinical practice.

3.
Clin Exp Rheumatol ; 30(5): 785-90, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23009763

RESUMO

This review will summarise the state of the art of salivary diagnostics in primary Sjögren's syndrome exploring the potential usefulness of both traditional and emerging biotechnologies for primary Sjögren's syndrome non-invasive and early detection.


Assuntos
Saliva/metabolismo , Glândulas Salivares/metabolismo , Síndrome de Sjogren/diagnóstico , Animais , Autoanticorpos/metabolismo , Biomarcadores/metabolismo , Citocinas/metabolismo , Diagnóstico Precoce , Humanos , Valor Preditivo dos Testes , Prognóstico , Proteômica , Saliva/imunologia , Glândulas Salivares/imunologia , Síndrome de Sjogren/imunologia , Síndrome de Sjogren/metabolismo
4.
Methods Mol Biol ; 1024: 183-90, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23719951

RESUMO

Oral cancer diagnosis can be greatly facilitated by early diagnosis in order to improve the 50 % 5-year mortality that has not changed much over the last years. Saliva is an easily accessible medium that has been shown to contain microvesicles (exosomes) that enclose microRNAs. We have previously demonstrated that the majority of salivary microRNAs are within exosomes. MicroRNAs have been implicated in oral cancer and the use of salivary exosomal microRNAs holds the promise of identification of diagnostic and prognostic markers.


Assuntos
Biomarcadores Tumorais/isolamento & purificação , Carcinoma de Células Escamosas/diagnóstico , Exossomos/química , MicroRNAs/isolamento & purificação , Neoplasias Bucais/diagnóstico , Saliva/química , Carcinoma de Células Escamosas/metabolismo , Carcinoma de Células Escamosas/patologia , Ácido Cítrico/farmacologia , Diagnóstico Precoce , Exossomos/ultraestrutura , Humanos , Microscopia Eletrônica , Neoplasias Bucais/metabolismo , Neoplasias Bucais/patologia , Glândula Parótida/efeitos dos fármacos , Glândula Parótida/metabolismo , Glândula Parótida/patologia , Reação em Cadeia da Polimerase em Tempo Real , Manejo de Espécimes , Fatores de Tempo
5.
PLoS One ; 7(3): e30679, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22427800

RESUMO

There is an increasing interest in using microRNAs (miRNA) as biomarkers in autoimmune diseases. They are easily accessible in many body fluids but it is controversial if they are circulating freely or are encapsulated in microvesicles, particularly exosomes. We investigated if the majority of miRNas in serum and saliva are free-circulating or concentrated in exosomes. Exosomes were isolated by ultracentrifugation from fresh and frozen human serum and saliva. The amount of selected miRNAs extracted from the exosomal pellet and the exosome-depleted serum and saliva was compared by quantitative RT-PCR. Some miRNAs tested are ubiquitously expressed, others were previously reported as biomarkers. We included miRNAs previously reported to be free circulating and some thought to be exosome specific. The purity of exosome fraction was confirmed by electronmicroscopy and western blot. The concentration of miRNAs was consistently higher in the exosome pellet compared to the exosome-depleted supernatant. We obtained the same results using an equal volume or equal amount of total RNA as input of the RT-qPCR. The concentration of miRNA in whole, unfractionated serum, was between the exosomal pellet and the exosome-depleted supernatant. Selected miRNAs, which were detectable in exosomes, were undetectable in whole serum and the exosome-depleted supernantant. Exosome isolation improves the sensitivity of miRNA amplification from human biologic fluids. Exosomal miRNA should be the starting point for early biomarker studies to reduce the probability of false negative results involving low abundance miRNAs that may be missed by using unfractionated serum or saliva.


Assuntos
Exossomos/química , MicroRNAs/análise , MicroRNAs/sangue , Saliva/química , Biomarcadores/análise , Biomarcadores/sangue , Western Blotting , Humanos , Microscopia Eletrônica , Reação em Cadeia da Polimerase Via Transcriptase Reversa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA